Karen S. Canady, Ph.D. is a founding partner of Canady + Lortz LLP.
Los Angeleskaren@canadylortz.com
Dr. Canady’s practice emphasizes biotechnology patent preparation and prosecution. She also counsels clients and prepares opinions relating to patentability, patent validity, infringement, freedom to operate, and other aspects of portfolio assessment. Some examples of her work include developing and prosecuting a portfolio of lentiviral gene delivery patents and applications that was sold by her client for $12 million, and evaluating a portfolio of antisense molecules to help a client close a deal involving a $45 million dollar upfront licensing fee and the potential for over $230 million in milestone payments.
While a law student, she worked part-time in the technology transfer office at the University of Washington, then gained experience in patent prosecution and litigation support at a Seattle intellectual property firm. Dr. Canady spent her first year after law school as a trainee with a European patent firm in Munich. After spending the next two and a half years with a mid-size intellectual property firm, she went on to found the biotechnology practice group at a small Los Angeles boutique firm, and in 2006, merged her practice with Origin Law to form Canady + Lortz LLP.
This broad-ranging intellectual property experience, coupled with her background in neurobiological research, provides a solid foundation for representing and advising clients in the pursuit and evaluation of patent rights, both domestically and abroad. Her experience in intellectual property law includes patent and trademark prosecution, client counseling and litigation support. She is frequently invited to speak at professional programs on various aspects of patent prosecution. Her prosecution practice has emphasized biotechnology, including diagnostic and therapeutic products and methods relating to recombinant DNA technology, vaccines, antibodies, stem cells, genomics and gene therapy.
An avid lover of bicycling, Dr. Canady frequently rides her bike in the hills and bike paths of the Los Angeles area and enjoys commuting around the city by bike.
Education
- University of Washington School of Law, JD
- University of Washington, PhD in Behavioral Neuroscience
- Pacific University, BS (Cum Laude)
Admissions
- California Bar
- United States Patent & Trademark Office
Professional Associations
- American Intellectual Property Law Association; currently serving as Vice-Chair of AIPLA Fellows; past roles include Amicus Committee, Board of Directors (2013–2016), Chair of the Biotechnology Committee (2009–2011), and Chair of the Women in Intellectual Property Law Committee (2003–2005)
- Foundation for Advancement of Diversity in Intellectual Property Law, Trustee (2017–present)
- Intellectual Property Section Executive Committee, State Bar of California (2009–2012); Advisor (2012–2013)
- Los Angeles Intellectual Property Law Association; Member, Board of Directors (2001–2003)
- Center for Advanced Study and Research on Intellectual Property, University of Washington School of Law; Member, Advisory Board (2002–2014)
Representative Patents
- 11,932,908: Compositions and methods for diagnosis and treatment of epilepsy
- 11,913,027: Methods of treatment using pluripotent human adipose adult stem cells
- 11,738,065: Polypeptides and analogues thereof for use in the treatment of diabetes and bone disorders
- 11,607,427: Method for chemoselection
- 11,576,982: Nipah virus envelope pseudotyped lentiviruses and methods of their use
- 11,512,351: Assay for pre-operative prediction of organ function recovery
- 11,385,232: Phenotypic profiling of hepatocellular carcinoma circulating tumor cells for treatment selection
- 11,377,659: Short hairpin RNA (shRNA734) and use of same to positively select and eliminate genetically modified cells
- 11,331,377: Vectors and methods for regenerative therapy
- 11,160,853: Breast and ovarian cancer vaccines
- 10,858,711: Primers, probes and methods for sensitive, specific detection and monitoring of HIV-1 and HCV
- 10,639,448: Cognition and memory enhancement via multiple odorant stimulation
- 10,451,636: Protein biomarkers for immune assessment and prediction of transplant rejection